TABLE 1.
Probe | Ligand | Competitor | SUVs | KD ligand | n | KD competitor | m | ro | rmax | Fmax/Fo |
---|---|---|---|---|---|---|---|---|---|---|
nm | mol/mol | nm | mol/mol | |||||||
[5F]FFR-NotD | FVa | 0.002 ± 0.01 | 0.79 ± 0.02 | 0.22 ± 0.002 | 0.27 ± 0.008 | 1.38 | ||||
[5F]FFR-NotD | FVa | Native NotD | 0.002 ± 0.04 | 0.76 ± 0.06 | 0.002 ± 0.04 | 1.6 ± 0.01 | 0.22 ± 0.002 | 0.27 ± 0.0008 | 1.34 | |
[5F]FFR-NotD | FVa | +a | 0.01 ± 0.02 | 0.85 ± 0.06 | 0.22 ± 0.002 | 0.27 ± 0.001 | 1.43 | |||
[5F]FFR-NotD | FV | 12 ± 1 | 0.79 ± 0.08 | 0.21 ± 0.002 | 0.27 ± 0.001 | 1.24 | ||||
[5F]FFR-NotD | FV | +a | 0.22 ± 0.06 | 0.69 ± 0.06 | 0.22 ± 0.002 | 0.28 ± 0.001 | 1.31 | |||
[OG]EGR-FXa | FV | +b | 1110 ± 250 | 1 | 0.23 ± 0.005 | 0.38 ± 0.001 | 1.06 | |||
[OG]EGR-FXa | FVa | FFR-NotD | +a | 0.3 ± 0.2 | 1 | 0.011 ± 0.008 | 1.4 ± 0.08 | 0.23 ± 0.004 | 0.29 ± 0.004 | 1.50 |
[OG]EGR-FXa | FVa | FFR-NotD | +c | 0.4 ± 0.3 | 1 | 0.007 ± 0.007 | 1.37 ± 0.07 | 0.23 ± 0.004 | 0.29 ± 0.004 | 1.54 |
[OG]EGR-FXa | FVa | +c | 0.8 ± 0.5 | 1.26 ± 0.07 | 0.22 ± 0.004 | 0.28 ± 0.002 | 1.44 |
a 50 μm PC/PS.
b 350 μm PC/PS/PE.
c 50 μm PC/PS/PE.